Clinical trial
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and…
NCT00157014 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00157014 |
|---|---|
| Title | Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens |
| Official title | Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Canada, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Diseases, Heart Transplantation |
| Intervention type | Drug |
| Interventions | Tacrolimus, Cyclosporine, Mycophenolate mofetil, Methylprednisolone, Prednisone |
| Enrollment | 111 |
| Start date | May 10, 2004 |
| Primary completion | Jul 18, 2008 |
| Completion | Jul 18, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 5, 2017 |
| Countries | Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: